•   
  •   
  •   

US FDA investigates lab as tens of thousands of COVID-19 test results in Florida are questioned

04:41  22 may  2020
04:41  22 may  2020 Source:   usatoday.com

The usefulness of the Covid-19 screening test campaign in France

 The usefulness of the Covid-19 screening test campaign in France © REUTERS / Christian Hartmann Laboratory staff work on blood samples, intended for serological tests for detection by coronavirus, on April 16 in Colmar . As of this week, 700,000 weekly tests for Covid-19 must take place in France. Tests that were very lacking at the start of the crisis with shortage situations. Today, however, the situation seems to have improved. This is necessary, because a massive screening policy is necessary to keep the epidemic under control. Locate, test, isolate.

Guidance on Interpreting COVID - 19 Test Results pdf icon[610 KB]external icon: A guide for interpreting test results and determining what actions to take. CDC has guidance for who should be tested, but decisions about testing are made by state and localexternal icon health departments or

See interim guidance for lab professionals working with specimens of persons under investigation For a list of COVID - 19 EUAs, see FDA ’s COVID - 19 Emergency Use Authorizations for Medical However, a negative result from viral testing does not rule out COVID - 19 . Most of the PCR-based

Federal regulators are investigating a Texas laboratory that a Florida hospital chain dropped last week because of delayed and unreliable COVID-19 test results.

AdventHealth, which has 45 hospitals in nine states, terminated its Florida contract with MicroGen DX due to concerns about the validity of some of the 60,000 tests MicroGen had processed for the system because the lab left them at room temperature for days, according to an AdventHealth statement. The specimens should be refrigerated at 2 to 7 degrees Celsius (about 32 degrees Fahrenheit) and then put in freezers at -70 degrees Celsius after three days, according to the Centers for Disease Control and Prevention.

British researchers want to solve genetic puzzle of Covid-19

 British researchers want to solve genetic puzzle of Covid-19 © Reuters / Peter Nicholls Outbreak of the coronavirus disease (COVID-19) in London London (Reuters) - In the UK, scientists want to study the genetic makeup of thousands of Covid-19 patients, To solve one of the puzzles surrounding the novel corona virus: Why do some people not even suffer from a mild headache while others die from it? The researchers want to sequence the genetic code of people who are seriously ill with Covid-19 and compare it with the genome of those in whom the disease was

Some are misusing antibody test results to diagnose the disease, not realizing that they can miss the Some test only for a transient antibody that spikes while the body is in the throes of an active Researchers are not certain that people who have recovered from Covid - 19 have immunity, though Makers of the tests have aggressively marketed them to businesses and doctors, and thousands of

Abbott's information on the test initially filed with the FDA listed a number of transport media that could be They processed more than 200 samples of Covid - 19 using five testing systems and found that ID New York's Northwell Health Labs , a private lab system serving hospitals in the state , has been

MicroGen promotes shipping COVID-19 sputum (mucus) samples through FedEx on its website.

Start the day smarter. Get all the news you need in your inbox each morning.

The company is also selling a saliva-only test that can be administered in a "hospital, clinic, drive-thru clinic or at-home,"  in all 50 states without an Emergency Use Authorization from the Food and Drug Administration, said spokeswoman Ashley Moore. An "authorized EUA" is required in a public health emergency, according to the FDA, for "any COVID-19 test for at-home testing, with or without the use of telemedicine."

Slideshow by photo services

FDA issues alert about 'possible accuracy concerns' with rapid coronavirus test used by White House

  FDA issues alert about 'possible accuracy concerns' with rapid coronavirus test used by White House The new MSN, Your customizable collection of the best in news, sports, entertainment, money, weather, travel, health, and lifestyle, combined with Outlook, Facebook, Twitter, Skype, and more.

The US Food and Drug Administration has authorized a saliva test for "emergency use" for diagnosing Covid - 19 . Rutgers University, where the test was developed in collaboration with other groups, announced the FDA authorization on Tuesday after formally receiving it over the weekend.

The US Food and Drug Administration has issued its first emergency use authorization for a coronavirus test that looks for antibodies in the blood. Thousands of people want to be exposed to Covid - 19 for science. South Dakota tribe refuses request to remove Covid - 19 checkpoints.

MicroGen CEO Rick Martin said he doesn't believe the company needs one. He filed for one anyway and said he believes FDA is taking too long to approve it. Companies can avoid EUAs unless they get state approval for use only in that state, the FDA said. Spokeswoman Ashley Moore said there were "no authorizations per say at the state level."

AdventHealth said it is notifying about 25,000 patients who got unreliable or delayed results. It is advising them to seek medical care and retesting if they tested negative but have COVID symptoms. Patients who tested positive should also seek retesting, AdventHealth said. It told the lab to destroy remaining tests and said its patients who haven’t received results from MicroGen DX will never receive them.

The dispute is expected to affect testing across the U.S. as MicroGen had an undisclosed number of other clients.

Fitbit hopes to make ventilators during the COVID-19 pandemic

  Fitbit hopes to make ventilators during the COVID-19 pandemic Fitbit wants to join the host of companies making ventilators during the COVID-19 pandemic. Company chief James Park told CNBC in an interview that Fitbit is shifting its production to make the potentially life-saving equipment, with plans to submit its technology to the FDA in the days ahead. And yes, the activity tracker brand is aware that it’s relatively late. Park said Fitbit would adjust its production to meet demand, whether the virus is (hopefully) fading away or begins a second wave as the world reopens.

COVID - 19 is a new disease, caused be a novel (or new) coronavirus that has not previously been Since it takes time to conduct laboratory testing , cases from a previous day may be added to the The symptoms of COVID - 19 are similar in children and adults. However, children with confirmed

The Florida Department of Health is issuing 2019 Novel Coronavirus ( COVID - 19 ) updates every day to keep residents and visitors safe and aware. What you need to know now about COVID - 19 in Florida . The elderly and those with underlying medical problems like high blood pressure, heart problems and

AdventHealth said Monday it "notified the appropriate regulatory agencies of the issues we experienced with this lab." Food and Drug Administration investigators are reviewing data and interviewing experts, according to emails reviewed by USA TODAY.

In a statement, Martin said he was unaware of "any inquiries into our lab," but added that after the AdventHealth announcement it started working with the American College of Pathologists on its testing requirements, "which we are confident we will continue to meet."

"We have not been contacted by the FDA about any matters related to our testing," said Martin. "We are confident that should we be contacted by the FDA, they will find we meet all requirements. We will fully cooperate with any inquiries." 

Unmet promises

AdventHealth also said the lab failed to meet promised turnaround times. Martin said MicroGen is processing samples at a rate of about 6,000 a day to serve hospitals and other clients across the U.S. That's below the 10,000 first promised or the 8,000 a month or more ago, but shows potentially mishandled tests could number in the hundreds of thousands. It has been conducting the tests daily since late March. 

First coronavirus case detected in Ecuador Amazon tribe

  First coronavirus case detected in Ecuador Amazon tribe The first case of the novel coronavirus has been detected in one of Ecuador's indigenous Amazon tribes, the health ministry said Sunday. Waorani organizations -- speaking through the GO Alliance for Human Rights in Ecuador (DDHH) -- warned COVID-19's spread could be "catastrophic and highly lethal" for their community, which is vulnerable to diseases.

Guidance on Interpreting COVID - 19 Test Results pdf icon[610 KB]external icon: A guide for interpreting test results and determining what It’s possible you might test positive for antibodies and you might not have or have ever had symptoms of COVID - 19 . This is known as having an

The U.S. Food and Drug Administration issued Emergency Use Authorization to Illinois-based medical device maker Abbott Labs on Friday for a coronavirus test that delivers positive results in as little as These tests that can give results quickly can be a game changer in diagnosing COVID - 19 ."

AdventHealth sent a team to MicroGen's lab after the results were delayed and saw samples left at room temperature, said MicroGen CEO Rick Martin. He maintains the samples were still valid and that the delays were due to AdventHealth not providing proper patient data and the lab running out of plastic parts used in its equipment.

MicroGen said in early April that its sputum (mucus) test was a way to circumvent the backlogs other labs were suffering due to lack of supplies. But the lab, which offers saliva, sputum and nasal swab tests, ended up facing its own supply shortages as it struggled to meet turnaround times it promised clients.

The wait for results grew from 24 to 48 hours to 10 to 12 days, Martin said.

The lab also processed hundreds of tests for the health system Health First, but the Florida-based chain stopped sending samples after it, too, began to see delays in turnaround time in early May, Martin said.

Health First would not respond to questions about the numbers of tests it sent to MicroGen, but the hospital chain issued a statement last week that said "most labs" it used were meeting their contracted 24-hour turnaround time.

While MicroGen is based in Orlando, its lab is in Lubbock, Texas. Martin said he had planned to move the lab to Florida, but "I'm not now" after this experience. 

A Florida man has been stuck on a ship for 62 days in an Italian port

  A Florida man has been stuck on a ship for 62 days in an Italian port Taylor Grimes, from Winter Springs, Florida, told CNN on Monday he has been stuck on a cruise ship and then a hospital ship in an Italian port for 62 days after testing positive for Covid-19 in early April. © Ann Grimes Taylor Grimes says he was on his second cruise as an employee of a Swiss-based cruise company when a coworker tested positive for Covid-19. "Some days are really bad and some days are OK," Taylor Grimes, 28, told CNN over video chat Monday. Grimes set sail mid-January from Genoa, Italy, on his second cruise as an employee of MSC Cruises, a global cruise company headquartered in Geneva, Switzerland.

How do labs get approved?

The dispute raises questions about how regulators and hospitals approve and choose labs.

Martin said he and his lab have a "great reputation." However, in January 2017, Martin's former employer Advanced BioHealing's parent company, Shire, paid $350 million in a civil settlement with the Justice Department in the anti-kick case. Martin was a sales representative accused of bribing Deparment of Veterans Affairs doctors to use the company’s DermaGraft biologic wound dressing. He was indicted in 2017 for allegedly participating in the fraud, but was acquitted at trial in February 2019.

The rush to ramp up coronavirus testing during the pandemic created a "wild west (that) opens the opportunity for fraud and abuse," said Dr. Rahul Gupta, a former West Virginia health commissioner, who oversaw that state's lab. The FDA, said Gupta, "should step up in providing more guidance, along with the CDC." 

"Delays signal an issue that may impact the integrity of the testing lab and its declared or promised timelines and procedures," said Gupta, now the chief medical and health officer for March of Dimes and a clinical professor at Georgetown University Medical School. "It’s most important to ensure you’re working with an established and trusted lab not a ‘fly by night set up’ as many are popping up."

After recent criticism, the Food and Drug Administration has become tougher on which tests get an "Emergency Use Authorization" to be sold. 

Georgia man arrested after allegedly faking coronavirus

  Georgia man arrested after allegedly faking coronavirus A Georgia man is facing federal charges after he was arrested for allegedly faking coronavirus. © Provided by WSB Atlanta Santwon Antonio Davis, 34, is charged with defrauding his employer, the U.S. attorney's office in Atlanta said in a news release Thursday. Because Davis said he'd tested positive, his employer had to shut down its plant for sanitizing and put several other employees on paid leave while they quarantined, causing the company a loss of more than $100,000, prosecutors said.

Getting these authorizations has “historically been a high bar,” but it is lower than the hurdle of the FDA's scientific safety review process for pre-market approval to sell, said Kelly Wroblewski, director of infectious diseases at the Association of Public Health Laboratories. EUAs are designed to “make it easier to get tests to market," she said. Companies don’t need to provide clinical performance data, but have to validate the tests. 

The FDA was approving EUAs faster earlier in the pandemic, but Wroblewski said the reviews appear to be more exacting now,

"There were at least some fences around molecular (COVID-19) testing all along," she said. "There was no bar around serology (antibody) testing." 

Martin said the FDA has been unusually tough on his company's lab in its pursuit of the EUA for saliva tests. Meanwhile, he said the FDA quickly approved Abbott Laboratories, whose tests had so many problems the agency issued a warning last week. 

Gupta said tighter federal controls are needed on "who can test, what tests are approved and ensuring that these facilities have all the equipment prior to advertising large capacities."

"Unfortunately, there are real people at the other end this time and lives will be surely lost," he said. 

Gaillion, a Florida Today business reporter, can be reached at bgallion@floridatoday.com. Follow O'Donnell, USA TODAY's health policy reporter,  @JayneODonnell on Twitter or email jodonnell@usatoday.com. 

This article originally appeared on USA TODAY: FDA investigates lab as tens of thousands of COVID-19 test results in Florida are questioned

Report: UFC institutes stricter COVID-19 protocol ahead of May 30 card .
Find out the latest on COVID-19's impact on the sports world and when sports are returning by subscribing to Breaking News push notifications in the Sports and COVID-19 section. The UFC is instituting stricter coronavirus protocols ahead of Saturday's event in Las Vegas. Fighters slated to compete at the UFC Apex this weekend received a memo outlining the new guidelines, according to ESPN's Ariel Helwani. The card, headlined by former welterweight champion Tyron Woodley versus Gilbert Burns, is still pending approval from the Nevada Athletic Commission, which will hold a meeting Wednesday.

—   Share news in the SOC. Networks
usr: 5
This is interesting!